Papers - NAKAGAWA Junichi
-
Abnormally high plasma concentrations of M-4, the active metabolite of edoxaban, at the onset of acute kidney injury in a patient receiving rifampin and clarithromycin: a case report.
J Pharm Health Care Sci 10 ( 1 ) 66 2024.10
-
Quantification of the Plasma Concentration of Vadadustat by High-Performance Liquid Chromatography with Ultraviolet Detection and Ultra-Performance Liquid Chromatography-Tandem Mass Spectrometry
Yokoyama S, Nakagawa J, Shimada M, Ueno K, Ishiyama M, Nakamura N, Tomita H, Niioka T.
Therapeutic Drug Monitoring 2024.7
-
Noninvasive Computed Tomography-Based Deep Learning Model Predicts In Vitro Chemosensitivity Assay Results in Pancreatic Cancer.
Kanda T, Wakiya T, Ishido K, Kimura N, Nagase H, Yoshida E, Nakagawa J, Matsuzaka M, Niioka T, Sasaki Y, Hakamada K.
2023.11
-
Influence of CYP3A5 and ABCB1 polymorphisms on the pharmacokinetics of vincristine in adult patients receiving CHOP therapy
Junichi Nakagawa, Takenori Takahata, Yu Chen, Kensuke Saito, Kosuke Kamata, Takuto Tachita, Satoru Yamashita, Keigo Saito, Kayo Ueno, Atsushi Sato, Hirotake Sakuraba, Takenori Niioka
Cancer Chemotherapy and Pharmacology 92 ( 5 ) 391 - 398 2023.8
-
Effect of pregnane X receptor and cytochrome P450 oxidoreductase gene polymorphisms on trough concentrations of rivaroxaban and edoxaban in patients with nonvalvular atrial fibrillation
Nakagawa J, Kinjo T, Aiuchi N, Ueno K, Tomita H, Niioka T
European Journal of Clinical Pharmacology 79 ( 5 ) 703 - 705 2023.5
-
Impact of solute carrier transporter gene polymorphisms on serum creatinine concentrations in healthy volunteers
Yokoyama S, Nakagawa J, Kudo M, Aiuchi N, Seito T, Isida M, Mikami T, Ihara K, Nakaji S, Niioka T
Pharmacol Res Perspect 11 ( 1 ) e01048 2023.1
-
Impacts of pregnane X receptor and cytochrome P450 oxidoreductase gene polymorphisms on trough concentrations of apixaban in patients with non-valvular atrial fibrillation.
Nakagawa J, Kinjo T, Aiuchi N, Ueno K, Tomita H, Niioka T
European Journal of Clinical Pharmacology 79 ( 1 ) 127 - 135 2022.11
-
Associations among plasma concentrations of edoxaban and M-4, prothrombin time, and the SLCO1B1*15 haplotype in patients with non-valvular atrial fibrillation.
Nakagawa J, Kinjo T, Aiuchi N, Ueno K, Tomita H, Niioka T.
Ther Drug Monit. 2022.9
-
Impact of trimethoprim on serum creatinine, sodium, and potassium concentrations in patients taking trimethoprim-sulfamethoxazole without changes in glomerular filtration rate.
Yokoyama S, Nakagawa J, Aiuchi N, Seito T, Niioka T.
J Clin Pharm Ther. 47 ( 9 ) 1409 - 1417 2022.9
-
Impact of polymorphisms of pharmacokinetics-related genes and the inflammatory response on the metabolism of voriconazole.
Aiuchi N, Nakagawa J, Sakuraba H, Takahata T, Kamata K, Saito N, Ueno K, Ishiyama M, Yamagata K, Kayaba H, Niioka T.
Pharmacol Res Perspect . 10(2) e00935 2022.4
-
Impact of gene polymorphisms in drug-metabolizing enzymes and transporters on trough concentrations of rivaroxaban in patients with atrial fibrillation.
Junichi Nakagawa, Takahiko Kinjo, Mei Iizuka, Kayo Ueno, Hirofumi Tomita, Takenori Niioka
Basic & clinical pharmacology & toxicology 128 ( 2 ) 297 - 304 2021.2
-
Evaluation for pharmacokinetic exposure of cytotoxic anticancer drugs in elderly patients receiving (R-)CHOP therapy.
Junichi Nakagawa, Takenori Takahata, Rui Hyodo, Yu Chen, Kengo Hasui, Kota Sasaki, Kensuke Saito, Kayo Ueno, Kazuhiro Hosoi, Kazufumi Terui, Atsushi Sato, Takenori Niioka
Scientific reports 11 ( 1 ) 785 - 785 2021.1
-
第37回日本TDM学会学術大会若手優秀演題賞を受賞して 「高齢者の (R)-CHOP療法におけるビンクリスチン, ドキソルビシンおよびシクロホスファミドの血中濃度-時間曲線下面積 (AUC) 個体間変動に関する検討」
中川潤一
TDM研究 38 ( 4 ) 107 - 110 2021
-
Relationship Between Change Rate of Tacrolimus Clearance During Continuous Intravenous Infusion and Recipient Recovery at an Early Stage After Living Donor Liver Transplantation.
Junichi Nakagawa, Keinosuke Ishido, Yuka Tono, Norihisa Kimura, Taiichi Wakiya, Yuji Okamura, Kenichi Hakamada, Takenori Niioka
European journal of drug metabolism and pharmacokinetics 2020.6
-
Passage of irinotecan and its active metabolite, SN-38, into human milk.
J Nakagawa, K Terui, K Hosoi, K Ueno, Y Yokoyama, M Hayakari
Journal of clinical pharmacy and therapeutics 41 ( 5 ) 579 - 582 2016.10